Marshall Wace North America’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-55,372
| Closed | -$1.75M | – | 1539 |
|
|
2021
Q1 | $1.75M | Buy |
+55,372
| New | +$1.75M | 0.01% | 845 |
|
|
2020
Q4 | – | Sell |
-44,724
| Closed | -$1.47M | – | 1427 |
|
|
2020
Q3 | $1.47M | Sell |
44,724
-289,448
| -87% | -$9.53M | 0.01% | 688 |
|
|
2020
Q2 | $9.17M | Buy |
334,172
+247,369
| +285% | +$6.79M | 0.06% | 278 |
|
|
2020
Q1 | $2.6M | Buy |
86,803
+77,955
| +881% | +$2.33M | 0.02% | 438 |
|
|
2019
Q4 | $245K | Buy |
+8,848
| New | +$245K | ﹤0.01% | 929 |
|
|
2019
Q3 | – | Sell |
-210,174
| Closed | -$5.15M | – | 1408 |
|
|
2019
Q2 | $5.15M | Sell |
210,174
-105,275
| -33% | -$2.58M | 0.03% | 356 |
|
|
2019
Q1 | $3M | Buy |
315,449
+247,321
| +363% | +$2.35M | 0.02% | 414 |
|
|
2018
Q4 | $603K | Sell |
68,128
-145,054
| -68% | -$1.28M | 0.01% | 735 |
|
|
2018
Q3 | $2.4M | Sell |
213,182
-324,486
| -60% | -$3.65M | 0.02% | 455 |
|
|
2018
Q2 | $6.88M | Sell |
537,668
-1,141,303
| -68% | -$14.6M | 0.04% | 431 |
|
|
2018
Q1 | $28.4M | Buy |
+1,678,971
| New | +$28.4M | 0.14% | 163 |
|
|
2017
Q3 | – | Sell |
-13,191
| Closed | -$92K | – | 1385 |
|
|
2017
Q2 | $92K | Buy |
+13,191
| New | +$92K | ﹤0.01% | 1254 |
|